Crinetics Pharmaceuticals (CRNX) News Today $29.11 +0.02 (+0.07%) As of 10:03 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CRNX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Crinetics Pharmaceuticals Receives FDA Orphan Drug Designation for Atumelnant in Treating Classic Congenital Adrenal Hyperplasia1 hour ago | quiverquant.comQCrinetics Receives FDA Orphan Drug Designation for Atumelnant in the Treatment of Congenital Adrenal Hyperplasia (CAH)2 hours ago | globenewswire.comVanguard Group Inc. Grows Position in Crinetics Pharmaceuticals, Inc. $CRNXAugust 19 at 3:46 AM | marketbeat.comCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Consensus Recommendation of "Moderate Buy" by AnalystsAugust 17, 2025 | marketbeat.comCrinetics Pharmaceuticals, Inc.: Crinetics Pharmaceuticals Announces August 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 13, 2025 | finanznachrichten.deJonesTrading Reaffirms Their Buy Rating on Crinetics Pharmaceuticals (CRNX)August 13, 2025 | theglobeandmail.comCrinetics Pharmaceuticals (CRNX) Receives a Buy from Evercore ISIAugust 13, 2025 | theglobeandmail.comCrinetics Pharma’s Earnings Call: Progress Amid ChallengesAugust 13, 2025 | msn.comJMP Securities Cuts Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $86.00August 12, 2025 | marketbeat.comJMP Securities Has Lowered Expectations for Crinetics Pharmaceuticals (NASDAQ:CRNX) Stock PriceAugust 12, 2025 | americanbankingnews.comCrinetics Pharmaceuticals Announces August 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 11, 2025 | globenewswire.comH.C. Wainwright Keeps Their Buy Rating on Crinetics Pharmaceuticals (CRNX)August 9, 2025 | theglobeandmail.comMorgan Stanley Reaffirms Their Buy Rating on Crinetics Pharmaceuticals (CRNX)August 9, 2025 | theglobeandmail.comCrinetics Pharmaceuticals, Inc. (CRNX) Q2 2025 Earnings Call TranscriptAugust 9, 2025 | seekingalpha.comCrinetics (CRNX) Q2 Revenue Jumps 150%August 7, 2025 | fool.comCrinetics Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 7, 2025 | globenewswire.comTD Asset Management Inc Decreases Stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)August 3, 2025 | marketbeat.comCrinetics Pharmaceuticals (CRNX) to Release Earnings on ThursdayAugust 1, 2025 | marketbeat.comCrinetics Pharmaceuticals, Inc. (CRNX)’ Oral Acromegaly Drug Nears FDA Decision After Strong Phase 3 DataJuly 31, 2025 | msn.comDecheng Capital LLC Has $5.97 Million Stock Holdings in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)July 30, 2025 | marketbeat.comFiera Capital Corp Sells 16,645 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)July 30, 2025 | marketbeat.comVictory Capital Management Inc. Trims Holdings in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)July 25, 2025 | marketbeat.comGW&K Investment Management LLC Boosts Stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)July 22, 2025 | marketbeat.comCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Average Recommendation of "Moderate Buy" from BrokeragesJuly 22, 2025 | marketbeat.comNew York State Common Retirement Fund Sells 17,508 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)July 22, 2025 | marketbeat.comLewis Asset Management LLC Boosts Holdings in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)July 21, 2025 | marketbeat.comCrinetics Pharmaceuticals (NASDAQ:CRNX) Shares Down 5.8% - Here's What HappenedJuly 19, 2025 | marketbeat.comJennison Associates LLC Lowers Holdings in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)July 19, 2025 | marketbeat.comCrinetics to Present New Long-Term Data Demonstrating Durable Control of Once-Daily, Oral PALSONIFY™ (Paltusotine) in Acromegaly at ENDO 2025July 13, 2025 | globenewswire.comCrinetics Pharmaceuticals Announces July 2025 Inducement Grants Under ...July 12, 2025 | morningstar.comMCrinetics Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 7, 2025July 11, 2025 | globenewswire.comCrinetics Pharmaceuticals, Inc.: Crinetics Pharmaceuticals Announces July 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 11, 2025 | finanznachrichten.deCrinetics Pharmaceuticals Announces July 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 10, 2025 | globenewswire.comCrinetics Pharmaceuticals (NASDAQ:CRNX) Now Covered by Analysts at The Goldman Sachs GroupJuly 10, 2025 | marketbeat.comCrinetics Pharmaceuticals (NASDAQ:CRNX) Shares Up 5.3% - Here's What HappenedJuly 9, 2025 | marketbeat.comShould You Hold Crinetics Pharmaceuticals (CRNX)?July 9, 2025 | msn.comCrinetics to Showcase the Next Generation of Endocrinology Innovation at ENDO 2025 with Eight Presentations From its Deep PipelineJune 30, 2025 | globenewswire.comCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Consensus Rating of "Moderate Buy" by AnalystsJune 27, 2025 | marketbeat.comCrinetics Pharmaceuticals (NASDAQ:CRNX) Earns Buy Rating from HC WainwrightJune 27, 2025 | marketbeat.comStephen F. Betz Sells 97,483 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) StockJune 17, 2025 | insidertrades.comInsider Selling: Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Insider Sells 97,483 Shares of StockJune 16, 2025 | marketbeat.comCrinetics Pharmaceuticals to Host R&D Day on June 26, 2025June 16, 2025 | globenewswire.comCrinetics Pharmaceuticals: Highly Priced Biotech Awaits PDUFA On Acromegaly DrugJune 16, 2025 | seekingalpha.comRhumbline Advisers Increases Stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)June 14, 2025 | marketbeat.comSG Americas Securities LLC Decreases Stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)June 11, 2025 | marketbeat.comCrinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 10, 2025 | globenewswire.comAnalysts Offer Predictions for CRNX FY2026 EarningsJune 10, 2025 | marketbeat.comTwo Sigma Advisers LP Sells 14,300 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)June 5, 2025 | marketbeat.comCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Shares Purchased by California State Teachers Retirement SystemJune 4, 2025 | marketbeat.comJane Street Group LLC Sells 122,188 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)June 1, 2025 | marketbeat.com Get Crinetics Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CRNX and its competitors with MarketBeat's FREE daily newsletter. Email Address CRNX Media Mentions By Week CRNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRNX News Sentiment▼0.950.50▲Average Medical News Sentiment CRNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRNX Articles This Week▼26▲CRNX Articles Average Week Get Crinetics Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CRNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies QIAGEN News Today Moderna News Today BridgeBio Pharma News Today Verona Pharma PLC American Depositary Share News Today Elanco Animal Health News Today Blueprint Medicines News Today Roivant Sciences News Today Grifols News Today Legend Biotech News Today Revolution Medicines News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRNX) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crinetics Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crinetics Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access